Use of medications for enlarged prostate not associated with suicide risk

A Canadian study of older men who took a 5‐alpha‐reductase inhibitor (5ARI) for the treatment of benign prostatic hyperplasia (BPH) has found no increased risk of suicide compared with men not receiving the medication. Risk of self‐harm and depression was greater in the medicated group during the first 18 months of treatment, however.
Source: The Brown University Psychopharmacology Update - Category: Psychiatry Tags: What's New in Research Source Type: research